Washington Report

Aug 01, 2009
Pharmaceutical Executive
Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.
Jul 01, 2009
Pharmaceutical Executive
As FDA looks to balance risks and benefits, more regulations are on the horizon.
Jun 01, 2009
Pharmaceutical Executive
FDA is seeking more resources to support compliance and oversight.
May 01, 2009
Pharmaceutical Executive
Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.
Apr 01, 2009
Pharmaceutical Executive
In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs.
Mar 01, 2009
Pharmaceutical Executive
The latest buzzword in pharma is "transparency"
Feb 01, 2009
Pharmaceutical Executive
A close look at the healthcare industry will separate real cost-cutting measures from money-saving myths.
Jan 01, 2009
Pharmaceutical Executive
Will more resourches and new leadership fix FDA, or is a major overhaul in order?
Dec 01, 2008
Pharmaceutical Executive
To expand health coverage amid an economic crisis, Obama will be looking hard for ways to cut costs
Nov 01, 2008
Pharmaceutical Executive
As Congress moves to curb industry influence, support for med ed is waning
native1_300x100
lorem ipsum